2020 annual financial data

ImmunityBio 2020 Financial results

ImmunityBio 2020 financial results with verified reported values.

Direct answer

Revenue was 605,000 USD.

Operating income was -220,880,000 USD and net income was -221,851,000 USD.
Operating cash flow was -171,724,000 USD.

Get free ImmunityBio email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
605,000 USD
Operating income
-220,880,000 USD
Net income
-221,851,000 USD
Operating cash flow
-171,724,000 USD